Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
1991-7-10
|
pubmed:abstractText |
Calcitonin gene methylation at CCGG sites were determined in 39 chronic myeloid leukemia patients by isoschizomeric restriction endonuclease analysis. A total of 27 patients were analyzed while still in the chronic phase: 20 patients had a normal gene, and seven had a hypermethylated gene. There were 12 patients initially studied in accelerated or blastic phases. All but one patient showed gene hypermethylation, suggesting a good correlation between gene methylation and disease stage. All five patients who, while still in the chronic phase, had a major 3.1-kb hypermethylated calcitonin gene fragment, accelerated within 2 to 27 months. In consecutively analyzed patients, the initially normal calcitonin gene changed to a hypermethylated state as the disease escalated. The hypermethylation predicted disease acceleration with a median lead time of 6 months before any morphologic or clinical signs of disease progression were seen. The disease progressed in 8 of 27 patients initially studied in the chronic phase: in only two patients this occurred without predictive methylation changes. The results suggest that the assessment of calcitonin gene methylation status may be a promising tool for monitoring chronic myeloid leukemia disease escalation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0006-4971
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
77
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2435-40
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2039824-Blast Crisis,
pubmed-meshheading:2039824-Bone Marrow,
pubmed-meshheading:2039824-Calcitonin,
pubmed-meshheading:2039824-DNA, Neoplasm,
pubmed-meshheading:2039824-Female,
pubmed-meshheading:2039824-Follow-Up Studies,
pubmed-meshheading:2039824-Genetic Markers,
pubmed-meshheading:2039824-Humans,
pubmed-meshheading:2039824-Leukemia, Myelogenous, Chronic, BCR-ABL Positive,
pubmed-meshheading:2039824-Leukocytes, Mononuclear,
pubmed-meshheading:2039824-Male,
pubmed-meshheading:2039824-Methylation,
pubmed-meshheading:2039824-Middle Aged,
pubmed-meshheading:2039824-Prognosis,
pubmed-meshheading:2039824-Restriction Mapping,
pubmed-meshheading:2039824-Tumor Markers, Biological
|
pubmed:year |
1991
|
pubmed:articleTitle |
Acceleration of chronic myeloid leukemia correlates with calcitonin gene hypermethylation.
|
pubmed:affiliation |
Department of Clinical Chemistry, University of Helsinki, Finland.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|